Ganessan Kichenadasse Selected Research

hydroxide ion

1/2018

Serum vitamin D decreases during chemotherapy: an Australian prospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ganessan Kichenadasse Research Topics

Disease

37	Neoplasms (Cancer) 06/2024 - 05/2011
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2019
9	Melanoma (Melanoma, Malignant) 01/2021 - 09/2017
6	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 03/2015
6	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 11/2013
5	Disease Progression 11/2023 - 01/2016
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 01/2016
5	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2015
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
4	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2019
3	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 01/2016
3	Glioma (Gliomas) 09/2023 - 01/2020
3	Exanthema (Rash) 01/2023 - 02/2020
3	Dysbiosis 01/2022 - 10/2020
2	Adenocarcinoma 04/2024 - 01/2022
2	Diarrhea 01/2023 - 10/2017
2	Ovarian Neoplasms (Ovarian Cancer) 06/2021 - 10/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Infections 10/2020 - 01/2020
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Ovarian Epithelial Carcinoma 10/2019 - 01/2017
2	Proteinuria 01/2018 - 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 06/2024
1	Overweight 03/2024
1	Skin Neoplasms (Skin Cancer) 01/2024
1	Mucositis 10/2023
1	Chronic Renal Insufficiency 07/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2022
1	Kidney Neoplasms (Kidney Cancer) 07/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 11/2021
1	Erythema 09/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2021
1	Seborrheic Dermatitis 09/2021
1	Keratoacanthoma 09/2021
1	Hand-Foot Syndrome 09/2021
1	Fallopian Tube Neoplasms 06/2021

Drug/Important Bio-Agent (IBA)

17	atezolizumabIBA 01/2022 - 08/2019
14	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2017
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2015
4	Proton Pump InhibitorsIBA 01/2022 - 10/2020
4	VemurafenibIBA 01/2021 - 01/2020
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 05/2011
3	IpilimumabIBA 11/2023 - 09/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 10/2017
3	Phosphotransferases (Kinase)IBA 06/2023 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2020
3	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2019
3	cobimetinibIBA 01/2021 - 01/2020
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 12/2017
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2019 - 12/2017
3	pazopanib FDA Link 01/2018 - 01/2016
2	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 01/2016
2	Medical MarijuanaIBA 10/2023 - 01/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 04/2018
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 09/2011
2	EnzymesIBA 11/2021 - 01/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021 - 01/2017
2	Serine (L-Serine)FDA Link 09/2021 - 11/2020
2	Sorafenib (BAY 43-9006)FDA Link 09/2021 - 01/2017
2	Docetaxel (Taxotere)FDA Link 12/2020 - 01/2020
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 12/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 12/2017
2	Sunitinib (Sutent)FDA Link 01/2018 - 01/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2016 - 03/2015
2	Monoclonal AntibodiesIBA 03/2016 - 12/2015
1	CytokinesIBA 06/2024
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	Sunscreening Agents (Sunscreens)IBA 01/2024
1	NivolumabIBA 11/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023
1	Acetazolamide (Diamox)FDA LinkGeneric 09/2023
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2023
1	perfluoropentane (perflenapent)IBA 01/2023
1	EmulsionsIBA 01/2023
1	pertuzumabIBA 01/2023
1	AlbuminsIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	olaparibIBA 11/2021
1	Threonine (L-Threonine)FDA Link 09/2021
1	tyrosine receptor (receptor, tyrosine)IBA 09/2021
1	Acitretin FDA Link 09/2021
1	4- (para- hydroxyphenyl)- 7,4'- dihydroxy- 3',5'- dimethoxy- 8- methylisoflavanIBA 06/2021
1	BenzopyransIBA 06/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Androgen Antagonists (Antiandrogens)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021

Therapy/Procedure

28	Therapeutics 06/2024 - 06/2010
20	Drug Therapy (Chemotherapy) 03/2024 - 09/2011
7	Immunotherapy 03/2024 - 01/2020
5	Radiotherapy 01/2023 - 01/2016
2	Nephrectomy 07/2022 - 01/2016
2	Drug Tapering 09/2021 - 01/2021
1	Oncolytic Virotherapy 06/2024
1	Chemoradiotherapy 10/2023
1	Neoadjuvant Therapy 01/2023
1	Radiofrequency Ablation 07/2022